Argus

•

Apr 06, 2026

Symbols

Sector(s)

Healthcare

Rating

Earnings Estimate

Current Price

$49.85

Price Target

Summary

Roche Holding AG operates through two segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment focuses on oncology, immunology, ophthalmology, infectious diseases and neuroscience, and the Diagnostics segment specializes in in vitro diagnostics. Headquartered in Basel, Switzerland, the company was founded by Fritz Hoffmann-La Roche in 1896.

The company has approximately 103,249 full-time employees.

Roche has substantial market shares in oncology treatments and in vitro diagnostics and is working to combine its experti

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level

Jasper Hellweg

Associate Analyst: Growth Pharmaceutical, Medical Technology & Financial Technology

At Argus Research, Jasper covers the Growth Pharmaceutical, Medical Technology, and Financial Technology companies. He received his undergraduate degree from Boston University, graduating cum laude with a Bachelor of Science degree in Business Administration with concentrations in Entrepreneurship and Marketing.  Prior to joining Argus, Jasper worked in a variety of industries, ranging from investment tradeshow management to musical instrument manufacturing.  He started his career at Argus in the Research department and has since widened his scope to also include becoming a regular contributor for the Market Movers and Market Digest publications, the Vickers Weekly Insider Report and Argus' bespoke research on IPOs.

Sign in to access your portfolio